Methylation status of TUSC3 is a prognostic factor in ovarian cancer.
Pils D, Horak P, Vanhara P, Anees M, Petz M, Alfanz A, Gugerell A, Wittinger M, Gleiss A, Auner V, Tong D, Zeillinger R, Braicu EI, Sehouli J, Krainer M.
Pils D, et al. Among authors: gleiss a.
Cancer. 2013 Mar 1;119(5):946-54. doi: 10.1002/cncr.27850. Epub 2012 Oct 23.
Cancer. 2013.
PMID: 23096450
Free article.